Shankara Paneesha

5PUBLICATIONS
43CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity.

|Apr 29, 2026
Acalabrutinib monotherapy as a first-line treatment for CLL: 3-year follow-up of the real-world EPIC study.

|Mar 06, 2026
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party.

Gesine Bug, Myriam Labopin, Jennifer L Byrne

|Apr 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial.

Sridhar Chaganti, Shanna Maycock, Graham McIlroy

|Dec 21, 2023
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.

Ann Tivey, Rohan Shotton, Toby A Eyre

Pageof 1

Frequent Collaborators

2 joint publications

Toby A Eyre

2 joint publications

John Snowden

2 joint publications

Arian Laurence

1 joint publications

Ann Tivey